Inspiration Healthcare Group PLC Notice of Results and Nomination for AIM Awards (6460Z)

TIDMIHC

RNS Number : 6460Z

Inspiration Healthcare Group PLC

22 September 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Notice of Results and Nomination for AIM Awards

Notice of Results

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company , will announce its unaudited interim results for the six months ended 31 July 2020 on Tuesday, 6 October 2020.

Neil Campbell, Chief Executive Officer and Jon Ballard, Chief Financial Officer will deliver an online results presentation open to all existing and potential investors on Tuesday, 6 October 2020 at 9.30 am UK time. The presentation will also allow for questions and answers and is expected to end at 11:00 am.

Details of the presentation and the access codes to attend will be forwarded to existing and potential investors who register their interest in advance with Alex Walters at Cadogan PR via email to [e-mail]

Investors will be able to submit questions before the event or at any time during the live presentation.

Nomination for AIM Awards

Inspiration Healthcare has been shortlisted for the Best Use of AIM Award and the AIM Transaction of the Year Award in the 25(th) AIM Awards sponsored by BDO in association with the London Stock Exchange. Voting will take place during November and December and details of the awards and voting can be seen at - http://www.aim-awards.co.uk/

Enquiries:

 
 Inspiration Healthcare Group plc          Tel: [phone] 
  Neil Campbell, Chief Executive Officer 
  Jon Ballard, Chief Financial Officer 
 Nominated Adviser & Broker                Tel: [phone] 
  Cenkos Securities plc 
  Mark Connelly 
  Stephen Keys 
  Cameron MacRitchie 
 Cadogan PR                                Tel: [phone] 
  Alex Walters 
  [e-mail] 
 

About Inspiration Healthcare Group

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products . The Group generates approximately 60% of its revenues from export markets and around two-thirds of its revenues come from its own-branded products.

With product availability actively promoted to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport. Further information on Inspiration Healthcare can be found at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCVFLFLBKLBBBE

(END) Dow Jones Newswires

September 22, 2020 02:00 ET (06:00 GMT)